Abstract
The Universal Definition of Myocardial Infarction globally endorses cardiac troponin (T and I; cTnT, cTnI) as the biomarker of choice for the diagnosis and assessment of acute coronary syndrome (ACS) and should be utilized routinely in patients with symptoms suggestive of acute myocardial infarction (AMI) [1]. Despite the widespread use of troponin in clinical practice there remain a number of pre-analytical, analytical and interpretive issues which can confound clinical interpretation and will likely be magnified with high-sensitivity troponin assays. The following case studies and discussion highlight some of these issues and nuances associated with troponin assays.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020–35.
Florkowski C, Wallace J, Walmsley T, George P. The effect of hemolysis on current troponin assays–a confounding preanalytical variable? Clin Chem. 2010;56:1195–7.
Lyon ME, Ball CL, Krause RD, Slotsve GA, Lyon AW. Effect of hemolysis on cardiac troponin T determination by the Elecsys 2010 immunoanalyzer. Clin Biochem. 2004;37:698–701.
Bais R. The effect of sample hemolysis on cardiac troponin I and T assays. Clin Chem. 2010;56:1357–9.
Ong ME, Chan YH, Lim CS. Observational study to determine factors associated with blood sample haemolysis in the emergency department. Ann Acad Med Singapore. 2008;37:745–8.
Sodi R, Darn SM, Davison AS, Stott A, Shenkin A. Mechanism of interference by haemolysis in the cardiac troponin T immunoassay. Ann Clin Biochem. 2006;43:49–56.
Katrukha AG, Bereznikova AV, Filatov VL, et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem. 1998;44:2433–40.
Koch CD, Wockenfus AF, Saenger AK, Jaffe AS, Karon BS. BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer. Clin Biochem. 2012;45:842–4.
Sonntag O. Haemolysis as an interference factor in clinical chemistry. J Clin Chem Clin Biochem. 1986;24:127–39.
Apple FS, Collinson PO, Biomarkers ITFoCAoC. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58:54–61.
Amundson BE, Apple FS. Cardiac troponin assays: a review of quantitative point-of-care devices and their efficacy in the diagnosis of myocardial infarction. Clin Chem Lab Med. 2015;53:665–76.
Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58:1574–81.
Aldous S, Mark Richards A, George PM, et al. Comparison of new point-of-care troponin assay with high sensitivity troponin in diagnosing myocardial infarction. Int J Cardiol. 2014;177:182–6.
Palamalai V, Murakami MM, Apple FS. Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction. Clin Biochem. 2013;46:1631–5.
Dupuy AM, Sebbane M, Roubille F, et al. Analytical evaluation of point of care cTnT and clinical performances in an unselected population as compared with central laboratory highly sensitive cTnT. Clin Biochem. 2015;48:334–9.
Singh J, Akbar MS, Adabag S. Discordance of cardiac troponin I assays on the point-of-care i-STAT and Architect assays from Abbott diagnostics. Clin Chim Acta. 2009;403:259–60.
Venge P, Ohberg C, Flodin M, Lindahl B. Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I. Am Heart J. 2010;160:835–41.
Loten C, Attia J, Hullick C, Marley J, McElduff P. Point of care troponin decreases time in the emergency department for patients with possible acute coronary syndrome: a randomised controlled trial. Emerg Med J. 2010;27:194–8.
Di Serio F, Antonelli G, Trerotoli P, Tampoia M, Matarrese A, Pansini N. Appropriateness of point-of-care testing (POCT) in an emergency department. Clin Chim Acta. 2003;333:185–9.
Apple FS, Ler R, Chung AY, Berger MJ, Murakami MM. Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome. Clin Chem. 2006;52:322–5.
Blick KE. The benefits of a rapid, point-of-care “TnI-Only” zero and 2-hour protocol for the evaluation of chest pain patients in the Emergency Department. Clin Lab Med. 2014;34:75–85, vi.
Collinson PO, John C, Lynch S, et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem. 2004;41:397–404.
Saenger AK, Beyrau R, Braun S, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011;412:748–54.
Tate JR, Bunk DM, Christenson RH, et al. Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project. Clin Chem Lab Med. 2015;53:677–90.
Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254–61.
Apple FS, Jaffe AS, Collinson P, et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem. 2015;48:201–3.
García-Mancebo ML, Agulló-Ortuño MT, Gimeno JR. Heterophile antibodies produce spuriously elevated concentrations of cardiac Troponin I in patients with Legionella pneumophila. Clin Biochem. 2005;38(6):584–7.
Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol. 2011;58:1819–24.
Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem. 2009;55:573–7.
Kavsak PA, Caruso N, Beattie J, Clark L. Centrifugation - an important pre-analytical factor for the Abbott Architect high-sensitivity cardiac troponin I assay. Clin Chim Acta. 2014;436:273–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Saenger, A.K. (2016). Pre-analytical Factors and Analytical Issues Affecting Interpretation of Cardiovascular Biomarkers. In: Maisel, A., Jaffe, A. (eds) Cardiac Biomarkers. Springer, Cham. https://doi.org/10.1007/978-3-319-42982-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-42982-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42980-9
Online ISBN: 978-3-319-42982-3
eBook Packages: MedicineMedicine (R0)